These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16209089)

  • 41. Mutation at embB codon 306, a potential marker for the identification of multidrug resistance associated with ethambutol in Mycobacterium tuberculosis.
    Cuevas-Córdoba B; Juárez-Eusebio DM; Almaraz-Velasco R; Muñiz-Salazar R; Laniado-Laborin R; Zenteno-Cuevas R
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5455-62. PubMed ID: 26124153
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Frequency of embB codon 306 mutations in ethambutol-susceptible and -resistant clinical Mycobacterium tuberculosis isolates in Kuwait.
    Ahmad S; Jaber AA; Mokaddas E
    Tuberculosis (Edinb); 2007 Mar; 87(2):123-9. PubMed ID: 17289435
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stazyme, a mycobacteriolytic preparation from a Staphylococcus strain, is able to break the permeability barrier in multiple drug resistant Mycobacterium avium.
    Rastogi N; Goh KS; Clavel-Sérès S
    FEMS Immunol Med Microbiol; 1997 Dec; 19(4):297-305. PubMed ID: 9537755
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Simultaneous ethambutol & isoniazid resistance in clinical isolates of Mycobacterium tuberculosis.
    Gupta P; Jadaun GP; Das R; Gupta UD; Srivastava K; Chauhan A; Sharma VD; Chauhan DS; Katoch VM
    Indian J Med Res; 2006 Feb; 123(2):125-30. PubMed ID: 16575110
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Truncated structural variants of lipoarabinomannan in ethambutol drug-resistant strains of Mycobacterium smegmatis. Inhibition of arabinan biosynthesis by ethambutol.
    Khoo KH; Douglas E; Azadi P; Inamine JM; Besra GS; Mikusová K; Brennan PJ; Chatterjee D
    J Biol Chem; 1996 Nov; 271(45):28682-90. PubMed ID: 8910503
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Sensitivity of m. kansasii strains to various antibiotics and chemotherapeutics in vitro and in vivo (author's transl)].
    Burjanová B; Dornetzhuber V
    Z Erkr Atmungsorgane; 1975 Jan; 142(1):68-77. PubMed ID: 58490
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Potentiation of the effects of chlorhexidine diacetate and cetylpyridinium chloride on mycobacteria by ethambutol.
    Broadley SJ; Jenkins PA; Furr JR; Russell AD
    J Med Microbiol; 1995 Dec; 43(6):458-60. PubMed ID: 7473681
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis.
    Bhusal Y; Shiohira CM; Yamane N
    Int J Antimicrob Agents; 2005 Oct; 26(4):292-7. PubMed ID: 16150578
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Drug sensitivity of the so-called atypical mycobacteria].
    Lucchesi M; Mancini P; Matzeu M
    Ann Ist Carlo Forlanini; 1968; 28(1):25-41. PubMed ID: 4314838
    [No Abstract]   [Full Text] [Related]  

  • 50. Topology and mutational analysis of the single Emb arabinofuranosyltransferase of Corynebacterium glutamicum as a model of Emb proteins of Mycobacterium tuberculosis.
    Seidel M; Alderwick LJ; Sahm H; Besra GS; Eggeling L
    Glycobiology; 2007 Feb; 17(2):210-9. PubMed ID: 17088267
    [TBL] [Abstract][Full Text] [Related]  

  • 51. New insights on Ethambutol Targets in Mycobacterium tuberculosis.
    Ghiraldi-Lopes LD; Campanerut-Sá PAZ; Evaristo GPC; Meneguello JE; Fiorini A; Baldin VP; de Souza EM; de Lima Scodro RB; Siqueira VLD; Cardoso RF
    Infect Disord Drug Targets; 2019; 19(1):73-80. PubMed ID: 29366429
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of embCAB gene mutations in ethambutol resistance in Mycobacterium tuberculosis isolates from India.
    Jadaun GP; Das R; Upadhyay P; Chauhan DS; Sharma VD; Katoch VM
    Int J Antimicrob Agents; 2009 May; 33(5):483-6. PubMed ID: 19112008
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel mutations in emb B gene of ethambutol resistant isolates of Mycobacterium tuberculosis: a preliminary report.
    Jain A; Mondal R; Srivastava S; Prasad R; Singh K; Ahuja RC
    Indian J Med Res; 2008 Nov; 128(5):634-9. PubMed ID: 19179685
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Testing Mycobacterium tuberculosis for drug sensitivity using different methods].
    Skriagina EM; Zalutskaia OM; Roth A; Mauch H; Nikolenko EN
    Probl Tuberk; 2001; (5):43-5. PubMed ID: 11588962
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro interaction of eupomatenoid-5 from Piper solmsianum C. DC. var. solmsianum and anti-tuberculosis drugs.
    Lopes MA; Ferracioli KR; Siqueira VL; de Lima Scodro RB; Cortez DA; da Silva RZ; Cardoso RF
    Int J Tuberc Lung Dis; 2014 Dec; 18(12):1513-5. PubMed ID: 25517821
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Comparison between bacteriophage-based assay and BACTEC-960 system in detection of ethambutol resistance in Mycobacterium tuberculosis].
    Ma XW; Hu ZY; Wang J; Zhang YR; Cui ZL; Cao XY; Weng XH
    Zhonghua Nei Ke Za Zhi; 2005 Mar; 44(3):202-5. PubMed ID: 15840261
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combinatorial lead optimization of [1,2]-diamines based on ethambutol as potential antituberculosis preclinical candidates.
    Lee RE; Protopopova M; Crooks E; Slayden RA; Terrot M; Barry CE
    J Comb Chem; 2003; 5(2):172-87. PubMed ID: 12625709
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Observations of properties of the L-form of M. tuberculosis induced by the antituberculosis drugs].
    Wang H; Chen Z
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 Jan; 24(1):52-5. PubMed ID: 11802941
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Blood agar for susceptibility testing of Mycobacterium tuberculosis against first-line drugs.
    Coban AY; Cihan CC; Bilgin K; Uzun M; Akgunes A; Cetinkaya E; Durupinar B
    Int J Tuberc Lung Dis; 2006 Apr; 10(4):450-3. PubMed ID: 16602412
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of wild-type MIC distributions as a tool for determination of clinical breakpoints for Mycobacterium tuberculosis.
    Schön T; Juréen P; Giske CG; Chryssanthou E; Sturegård E; Werngren J; Kahlmeter G; Hoffner SE; Angeby KA
    J Antimicrob Chemother; 2009 Oct; 64(4):786-93. PubMed ID: 19633001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.